In this Day 1 edition, Nuha El Sayed summarises the Updates of Standards of Care 2024 symposium, and Michael Roden gives a brief overview of the common ground of diabetes, obesity and MASLD, also referencing the EASL-EASD-EASO Guidelines recently published in Diabetologia and the Journal of Hepatology. A standout moment for EASD Vice-President Francesco Giorgino was the presentation of the SURMOUNT OSA trial results, published in the New England Journal of Medicine a day earlier. The trial explored the potential of tirzepatide as a treatment for obstructive sleep apnea in obesity – Giorgino sums up the key results in the Day 1 Newsflash.